Stockholm - Delayed Quote SEK
Oncopeptides AB (publ) (ONCO.ST)
1.9700
-0.0500
(-2.48%)
At close: May 22 at 5:29:54 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-260,570
-260,570
-279,493
-420,509
-1,516,391
Investing Cash Flow
496
496
-116
-2,507
-339
Financing Cash Flow
263,814
263,814
108,613
392,402
1,034,030
End Cash Position
178,536
178,536
173,407
344,515
362,187
Capital Expenditure
-2,628
-357
-116
-2,507
-339
Issuance of Capital Stock
1,316,836
--
0
435,611
1,116,488
Issuance of Debt
--
--
116,024
0
--
Repayment of Debt
-3,956
--
--
--
--
Free Cash Flow
-260,570
-260,570
-279,493
-423,016
-1,516,730
12/31/2021 - 2/22/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CANTA.ST Cantargia AB (publ)
1.5720
+0.77%
ACTI.ST Active Biotech AB (publ)
0.1566
-7.88%
COMBI.ST CombiGene AB (publ)
2.5000
-2.34%
NANECH.ST NanoEcho AB
0.1030
-5.33%
VICO.ST Vicore Pharma Holding AB (publ)
7.99
-3.27%
LPGO.ST Lipigon Pharmaceuticals AB (publ)
0.0958
+0.21%
XINT.ST Xintela AB (publ)
0.4800
-2.83%
ATORX.ST Alligator Bioscience AB (publ)
3.9000
0.00%
ISOFOL.ST Isofol Medical AB (publ)
1.1990
-0.08%
ACE.ST Ascelia Pharma AB (publ)
4.2200
-0.82%